lördag den 23 november

Arenbos uppmaning: Ta efter aktivisterna

Torbjörn Arenbo
Stockholmsbörsen
(), idag
-
-

Lipigon Pharmaceuticals
Lipigon Q3 2024: First Patient Recruited (Redeye)

2024-11-21 14:00
Redeye comments on Lipigon’s third quarter report 2024. The same day as the report was released, the company communicated the enrolment of the first patient in the ongoing phase II study of Lipisense.

info@redeye.se (Redeye.se)
Redeye AB - Redeye.se

Lipigon Pharmaceuticals - I dag

{point.key}

Senaste nytt

Visa alla telegram

Marknadsöversikt

Stockholmsbörsen, OMXS30

I dag
-
Senast
-
{point.key}

Världsindex
Index +/- % Senast
DAX - -
Hang Seng - -
Nikkei - -

Valutor
Valuta +/- % Senast
USD/SEK - -
EUR/SEK - -
GBP/SEK - -
EUR/USD - -

Räntor
Ränta +/- % Senast
5-års ränta - -
10-års ränta - -

Råvaror
Råvara +/- % Senast
Guld - -
Silver - -
Koppar - -